Kodiak Sciences (KOD)
(Delayed Data from NSDQ)
$2.81 USD
+0.05 (1.81%)
Updated Jun 14, 2024 04:00 PM ET
After-Market: $2.81 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth A Momentum B VGM
Brokerage Reports
Kodiak Sciences Inc. [KOD]
Reports for Purchase
Showing records 61 - 80 ( 127 total )
Company: Kodiak Sciences Inc.
Industry: Medical - Biomedical and Genetics
Company: Kodiak Sciences Inc.
Industry: Medical - Biomedical and Genetics
3Q21 Update - Pivotal Readouts Expected in 2022/2023 to Support BLA Filing
Provider: Roth Capital Partners, Inc.
Analyst: JALLAH Z
Company: Kodiak Sciences Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Kodiak Sciences Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Kodiak Sciences Inc.
Industry: Medical - Biomedical and Genetics
Company: Kodiak Sciences Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Kodiak Sciences Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Kodiak Sciences Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Kodiak Sciences Inc.
Industry: Medical - Biomedical and Genetics
2Q2021 Update - Clinical Catalysts in 2022 Should Move KOD Much Higher
Provider: Roth Capital Partners, Inc.
Analyst: JALLAH Z
Company: Kodiak Sciences Inc.
Industry: Medical - Biomedical and Genetics
Company: Kodiak Sciences Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Kodiak Sciences Inc.
Industry: Medical - Biomedical and Genetics
2H2021 Catalyst Calendar: Positive Outlook On Our Coverage & The Sector
Provider: Roth Capital Partners, Inc.
Analyst: JALLAH Z
Company: Kodiak Sciences Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Kodiak Sciences Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Kodiak Sciences Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Kodiak Sciences Inc.
Industry: Medical - Biomedical and Genetics
1Q21 Update- Pullback Creates Buying Opportunity Upgrading to Buy, $149 PT
Provider: Roth Capital Partners, Inc.
Analyst: JALLAH Z
Company: Kodiak Sciences Inc.
Industry: Medical - Biomedical and Genetics
1Q21 Update- Pullback Creates Buying Opportunity Upgrading to Buy, $149 PT
Provider: Roth Capital Partners, Inc.
Analyst: JALLAH Z
Company: Kodiak Sciences Inc.
Industry: Medical - Biomedical and Genetics
1Q21 Update- Pullback Creates Buying Opportunity Upgrading to Buy, $149 PT
Provider: Roth Capital Partners, Inc.
Analyst: JALLAH Z
Company: Kodiak Sciences Inc.
Industry: Medical - Biomedical and Genetics
Company: Kodiak Sciences Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department